Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationships between KRAS mutation status and baseline radiographic distribution of disease in patients with stage IV colorectal cancer.

Abdominal imaging - 1 Dec 2014

Rosenthal Michael H, Kim Kyung Won, Fuchs Charles S, Meyerhardt Jeffrey A, Ramaiya Nikhil H

Abstract excerpt

PURPOSE: KRAS oncogene testing is recommended in all patients with metastatic colorectal cancer due to its impact on treatment selection, but we do not know if KRAS genotype affects extent or pattern of metastases. We investigated whether the initial radiographic distribution of disease varies by KRAS genotype in stage IV colorectal cancer. MATERIALS AND METHODS: This retrospective study of 65 patients with stage...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Observer Variation

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Tomography, X-Ray Computed

Source

Open in PubMed Open full text

Identifiers

PMID: 24906690
DOI: 10.1007/s00261-014-0165-2
PMCID: PMC4346357

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationships between KRAS mutation status and baseline radiographic distribution of disease in patients with stage IV colorectal cancer.PMID 24906690Read ↗

Correlation between KRAS mutation and 18F-FDG uptake in stage IV colorectal cancer.Semantic proximity Read ↗

The Impact of KRAS Mutation on the Presentation and Prognosis of Non-Metastatic Colon Cancer: an Analysis from the National Cancer Database.Semantic proximity Read ↗

Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.Semantic proximity Read ↗

KRAS Testing, Tumor Location, and Survival in Patients With Stage IV Colorectal Cancer: SEER 2010-2013.Semantic proximity Read ↗

KRAS status in patients with colorectal cancer peritoneal carcinomatosis and its impact on outcome.Semantic proximity Read ↗

The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: An international, multi-institutional study in patients with known KRAS, BRAF, and MSI status.Semantic proximity Read ↗

Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study.Semantic proximity Read ↗

The adiposity of CRLM before targeted therapy initiation may serve as a marker to distinguish KRAS mutation status：A retrospective studySemantic proximity Read ↗

Metastatic colorectal cancer treatment patterns according to kirsten rat sarcoma viral oncogene homolog genotype in U.S. Community-based oncology practices.Semantic proximity Read ↗

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.Semantic proximity Read ↗

Histopathological growth patterns determines the outcomes of colorectal cancer liver metastasis that have undergone liver resectionSemantic proximity Read ↗

Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.